ERS Podcast | Treatment of drug-susceptible and drug-resistant TB: where we are and where we go

In the latest ERS Podcast Moderator Giovanni Battista Migliori is joined by Simon Tiberi and Onno Akkerman to discuss the new available options to reduce the treatment duration for drug-susceptible patients to 4 months and for MDR-TB patients to 6 months by discussing the important ongoing trials. The speakers also discuss the ideal organization of a clinical department to ensure adequate infection control and the modern approach to monitor the blood levels of anti-TB drugs. Disclaimer from Simon Tiberi: I am an employee of GSK. The opinions shared in this podcast are my own and not the views of my employer.

Listen on Soundcloud

Listen on Spotify

Recent episodes

Watch previous episodes

Load more